318 related articles for article (PubMed ID: 22447512)
1. Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model.
Tomassini B; Arcuri G; Fortuni S; Sandi C; Ezzatizadeh V; Casali C; Condò I; Malisan F; Al-Mahdawi S; Pook M; Testi R
Hum Mol Genet; 2012 Jul; 21(13):2855-61. PubMed ID: 22447512
[TBL] [Abstract][Full Text] [Related]
2. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
[TBL] [Abstract][Full Text] [Related]
3. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
[TBL] [Abstract][Full Text] [Related]
5. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
[TBL] [Abstract][Full Text] [Related]
6. Frataxin gene editing rescues Friedreich's ataxia pathology in dorsal root ganglia organoid-derived sensory neurons.
Mazzara PG; Muggeo S; Luoni M; Massimino L; Zaghi M; Valverde PT; Brusco S; Marzi MJ; Palma C; Colasante G; Iannielli A; Paulis M; Cordiglieri C; Giannelli SG; Podini P; Gellera C; Taroni F; Nicassio F; Rasponi M; Broccoli V
Nat Commun; 2020 Aug; 11(1):4178. PubMed ID: 32826895
[TBL] [Abstract][Full Text] [Related]
7. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
[TBL] [Abstract][Full Text] [Related]
8. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.
Shan Y; Schoenfeld RA; Hayashi G; Napoli E; Akiyama T; Iodi Carstens M; Carstens EE; Pook MA; Cortopassi GA
Antioxid Redox Signal; 2013 Nov; 19(13):1481-93. PubMed ID: 23350650
[TBL] [Abstract][Full Text] [Related]
9. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
Li H; Gakh O; Smith DY; Ranatunga WK; Isaya G
J Biol Chem; 2013 Feb; 288(6):4116-27. PubMed ID: 23269675
[TBL] [Abstract][Full Text] [Related]
10. Friedreich's ataxia--a case of aberrant transcription termination?
Butler JS; Napierala M
Transcription; 2015; 6(2):33-6. PubMed ID: 25831023
[TBL] [Abstract][Full Text] [Related]
11. GRP75 overexpression rescues frataxin deficiency and mitochondrial phenotypes in Friedreich ataxia cellular models.
Dong YN; McMillan E; Clark EM; Lin H; Lynch DR
Hum Mol Genet; 2019 May; 28(10):1594-1607. PubMed ID: 30590615
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia.
Nabhan JF; Wood KM; Rao VP; Morin J; Bhamidipaty S; LaBranche TP; Gooch RL; Bozal F; Bulawa CE; Guild BC
Sci Rep; 2016 Feb; 6():20019. PubMed ID: 26883577
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.
Misiorek JO; Schreiber AM; Urbanek-Trzeciak MO; Jazurek-Ciesiołka M; Hauser LA; Lynch DR; Napierala JS; Napierala M
Mol Neurobiol; 2020 Jun; 57(6):2639-2653. PubMed ID: 32291635
[TBL] [Abstract][Full Text] [Related]
14. Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia.
Grant L; Sun J; Xu H; Subramony SH; Chaires JB; Hebert MD
FEBS Lett; 2006 Oct; 580(22):5399-405. PubMed ID: 16989817
[TBL] [Abstract][Full Text] [Related]
15. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes.
Li J; Rozwadowska N; Clark A; Fil D; Napierala JS; Napierala M
Stem Cell Res; 2019 Oct; 40():101529. PubMed ID: 31446150
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich's ataxia.
Hackett PT; Jia X; Li L; Ward DM
J Biol Chem; 2022 Jun; 298(6):101982. PubMed ID: 35472330
[TBL] [Abstract][Full Text] [Related]
17. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.
Chan PK; Torres R; Yandim C; Law PP; Khadayate S; Mauri M; Grosan C; Chapman-Rothe N; Giunti P; Pook M; Festenstein R
Hum Mol Genet; 2013 Jul; 22(13):2662-75. PubMed ID: 23474817
[TBL] [Abstract][Full Text] [Related]
18. Effect of Mitochondrial and Cytosolic FXN Isoform Expression on Mitochondrial Dynamics and Metabolism.
Agrò M; Díaz-Nido J
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158039
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.
Mollá B; Muñoz-Lasso DC; Calap P; Fernandez-Vilata A; de la Iglesia-Vaya M; Pallardó FV; Moltó MD; Palau F; Gonzalez-Cabo P
Neurotherapeutics; 2019 Apr; 16(2):432-449. PubMed ID: 30761510
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
